Who to call at C4 THERAPEUTICS, INC., and when
Fundz watches for the moments C4 THERAPEUTICS, INC. starts buying, and tells you who to reach.
- An alert the day C4 THERAPEUTICS, INC. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at C4 THERAPEUTICS, INC., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at C4 THERAPEUTICS, INC.. With Fundz connected, it knows.
C4 THERAPEUTICS, INC.
The company shared information publicly (Regulation FD). An 8-K is the notice a US public company must file within four business days of a major event.
c4therapeutics.comAI Executive Summary
AI-powered analysis of 8-K filing content
C4 Therapeutics announced new biomarker data from Phase 1 trials of Cemsidomide with Dexamethasone and Phase 1b trials of Elranatamab (ELREXFIO®) for relapsed/refractory Multiple Myeloma at the 23rd International Myeloma Society Annual Meeting, signaling clinical progress that could strengthen the company's pipeline and investor confidence.
Key Takeaways
C4 Therapeutics presented new biomarker data from Cemsidomide Phase 1 trial in combination with Dexamethasone for Multiple Myeloma treatment
Phase 1b trial data for Elranatamab (ELREXFIO®) was shared, demonstrating advancements in relapsed/refractory Multiple Myeloma treatment
2 more takeaways
Filing Overview
What This Means
C4 THERAPEUTICS, INC. filed with the SEC. Fundz turns 8-K material events into an alert with the right executive attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
4 screens from a live account. No signup.